CVS Health Corp (NYSE:CVS) Shares Sold by Central Bank & Trust Co.

Central Bank & Trust Co. reduced its position in shares of CVS Health Corp (NYSE:CVS) by 11.8% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 2,830 shares of the pharmacy operator’s stock after selling 379 shares during the quarter. Central Bank & Trust Co.’s holdings in CVS Health were worth $178,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the stock. Baldwin Brothers Inc. MA grew its stake in shares of CVS Health by 1.1% in the third quarter. Baldwin Brothers Inc. MA now owns 14,911 shares of the pharmacy operator’s stock worth $941,000 after purchasing an additional 165 shares in the last quarter. Mutual Advisors LLC grew its stake in shares of CVS Health by 0.8% in the second quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock worth $1,125,000 after purchasing an additional 172 shares in the last quarter. Fiduciary Group LLC grew its stake in shares of CVS Health by 3.2% in the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock worth $353,000 after purchasing an additional 200 shares in the last quarter. Legacy Advisors LLC grew its stake in shares of CVS Health by 2.5% in the third quarter. Legacy Advisors LLC now owns 8,048 shares of the pharmacy operator’s stock worth $508,000 after purchasing an additional 200 shares in the last quarter. Finally, Carlton Hofferkamp & Jenks Wealth Management LLC grew its stake in shares of CVS Health by 1.5% in the third quarter. Carlton Hofferkamp & Jenks Wealth Management LLC now owns 13,255 shares of the pharmacy operator’s stock worth $824,000 after purchasing an additional 201 shares in the last quarter. 76.12% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts recently weighed in on the company. Cowen set a $76.00 target price on CVS Health and gave the company a “buy” rating in a research note on Monday. Morgan Stanley raised their target price on CVS Health from $74.00 to $77.00 and gave the company an “overweight” rating in a research note on Thursday, September 26th. Evercore ISI set a $63.00 target price on CVS Health and gave the company a “buy” rating in a research note on Wednesday, August 7th. TheStreet raised CVS Health from a “c+” rating to a “b-” rating in a research note on Monday, September 9th. Finally, Bank of America raised their target price on CVS Health from $72.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, September 12th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $75.39.

Shares of NYSE CVS traded down $0.19 during mid-day trading on Thursday, hitting $65.41. 1,033,130 shares of the company traded hands, compared to its average volume of 6,193,513. CVS Health Corp has a 1 year low of $51.72 and a 1 year high of $82.15. The stock has a market capitalization of $86.56 billion, a price-to-earnings ratio of 9.24, a PEG ratio of 1.45 and a beta of 0.86. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The business has a 50 day moving average of $63.27 and a two-hundred day moving average of $57.42.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the consensus estimate of $1.70 by $0.19. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same period in the prior year, the business posted $1.69 earnings per share. CVS Health’s revenue was up 35.2% compared to the same quarter last year. As a group, research analysts anticipate that CVS Health Corp will post 6.98 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, November 4th. Stockholders of record on Thursday, October 24th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.06%. The ex-dividend date is Wednesday, October 23rd. CVS Health’s dividend payout ratio is 28.25%.

In other news, EVP Joshua Matthew Flum sold 17,703 shares of the company’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $63.00, for a total transaction of $1,115,289.00. Following the completion of the sale, the executive vice president now directly owns 36,163 shares of the company’s stock, valued at $2,278,269. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Eva C. Boratto sold 8,130 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $65.00, for a total value of $528,450.00. Following the sale, the chief financial officer now directly owns 55,273 shares of the company’s stock, valued at $3,592,745. The disclosure for this sale can be found here. Corporate insiders own 0.53% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: What is a Special Dividend?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.